Fundai

Loghman Pharmaceutical and Hygiene Company (LOGHMANPHARMA) income statement

Operating revenue through to net profit and earnings per share

Ticker
LOGHMANPHARMA
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Operating revenue28,189,34410,297,0424,237,7376,100,6832,119,8951,025,725
Cost of operating revenue-10,606,269-7,308,593-3,747,181-4,582,416-1,552,488-832,684
Gross profit (loss)17,583,0752,988,449490,5561,518,267567,407193,041
Selling, general and administrative expenses-1,086,084-540,609-318,242-254,907-130,565-91,587
Other expenses-40,711-31,8700-46,7290-24,738
Operating profit (loss)16,456,2802,415,970173,8651,216,631436,84276,716
Finance costs-1,727,371-610,033-290,493-276,868-191,953-39,737
Other non-operating income and expenses9,7781,900,882173,57729,1901,013,44666,228
Profit (loss) from continuing operations before tax14,738,6873,706,81956,949968,9531,258,335103,207
Current year tax-2,643,733-324,277-7,132-175,454-43,871-10,351
Net profit (loss) from continuing operations12,094,9543,382,54249,817793,4991,214,46492,572
Net profit (loss)12,094,9543,382,54249,817793,4991,214,46492,572
Basic earnings (loss) per share1,181 rials502 rials7 rials118 rials180 rials137 rials
Net earnings (loss) per share, rials1,182 rials503 rials8 rials118 rials181 rials0 rials
Capital10,235,1506,735,1506,735,1506,735,1506,735,150675,000

Reporting periods

97 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.